This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Feb;7(2):123-6.

doi: 10.1002/jbmr.5650070202.

Posttransplantation bone disease

I A Katz¹, S Epstein

Affiliations

PMID: 1570757
DOI: 10.1002/jbmr.5650070202

Review

Posttransplantation bone disease

I A Katz et al. J Bone Miner Res. 1992 Feb.

. 1992 Feb;7(2):123-6.

doi: 10.1002/jbmr.5650070202.

Authors

I A Katz¹, S Epstein

Affiliation

¹ Division of Endocrinology and Metabolism, Albert Einstein Medical Center, Philadelphia, Pennsylvania.

PMID: 1570757
DOI: 10.1002/jbmr.5650070202

No abstract available

PubMed Disclaimer

Similar articles

Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton.
Epstein S. Epstein S. J Bone Miner Res. 1996 Jan;11(1):1-7. doi: 10.1002/jbmr.5650110102. J Bone Miner Res. 1996. PMID: 8770690 Review. No abstract available.
Bone disorders after organ transplantation.
Goffin E, Devogelaer JP. Goffin E, et al. Transplant Proc. 2005 Jul-Aug;37(6):2832-3. doi: 10.1016/j.transproceed.2005.05.015. Transplant Proc. 2005. PMID: 16182824 Review.
Chronic cyclosporine nephrotoxicity in rheumatoid arthritis.
Pei Y. Pei Y. J Rheumatol. 1996 Jan;23(1):4-5. J Rheumatol. 1996. PMID: 8838500 No abstract available.
Criteria for use of cyclosporine in adult transplant recipients.
Ninno MA, Davis SK. Ninno MA, et al. Clin Pharm. 1993 Sep;12(9):696-8. Clin Pharm. 1993. PMID: 8306570 No abstract available.
Posttransplantation bone disease.
Cunningham J. Cunningham J. Transplantation. 2005 Mar 27;79(6):629-34. doi: 10.1097/01.tp.0000149698.79739.ef. Transplantation. 2005. PMID: 15785362 Review.

See all similar articles

Cited by

Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate.
Meys E, Terreaux-Duvert F, Beaume-Six T, Dureau G, Meunier PJ. Meys E, et al. Osteoporos Int. 1993 Dec;3(6):322-9. doi: 10.1007/BF01637318. Osteoporos Int. 1993. PMID: 8292843
Bone loss after allogeneic haematopoietic stem cell transplantation: a pilot study on the use of zoledronic Acid.
Hausmann A, Hill W, Stemmler HJ, Ledderose G, Baur-Melnyk A, Fritsch S, Ullmann J, Kolb HJ, Geiger S, Tischer J. Hausmann A, et al. Chemother Res Pract. 2012;2012:858590. doi: 10.1155/2012/858590. Epub 2012 Apr 10. Chemother Res Pract. 2012. PMID: 22550587 Free PMC article.
Parathyroid function in cardiac transplant patients: evaluation during physical exercise.
Brandenberger G, Schnedecker B, Spiegel K, Mettauer B, Geny B, Sacrez J, Lampert E, Lonsdorfer J. Brandenberger G, et al. Eur J Appl Physiol Occup Physiol. 1995;70(5):401-6. doi: 10.1007/BF00618490. Eur J Appl Physiol Occup Physiol. 1995. PMID: 7671874
Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats.
Joffe I, Katz I, Sehgal S, Bex F, Kharode Y, Tamasi J, Epstein S. Joffe I, et al. Calcif Tissue Int. 1993 Jul;53(1):45-52. doi: 10.1007/BF01352014. Calcif Tissue Int. 1993. PMID: 8348384
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies.
Tauchmanovà L, Selleri C, Esposito M, Di Somma C, Orio F Jr, Bifulco G, Palomba S, Lombardi G, Rotoli B, Colao A. Tauchmanovà L, et al. Osteoporos Int. 2003 Dec;14(12):1013-9. doi: 10.1007/s00198-003-1520-2. Epub 2003 Sep 30. Osteoporos Int. 2003. PMID: 14517597 Clinical Trial.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information